Results 241 to 250 of about 56,165 (274)

Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies.

Journal of the neurological sciences, 1989
The progression of clinical disease and serum creatine kinase (CK) levels in canine X-linked muscular dystrophy (CXMD) was studied in 7 dogs from birth to 12-14 months and in 18 dogs at varying intervals from birth to 8 weeks. One affected male was studied from age 3.5 to 6 years, and all pups were descendants of this dog.
B A, Valentine, B J, Cooper, A, de Lahunta, R, O'Quinn, J T, Blue   +4 more
openaire   +1 more source

Animal models of muscular dystrophy – what can they teach us?

Neuropathology and Applied Neurobiology, 1991
The discovery and characterization of the X‐linked gene which is defective in Duchenne muscular dystrophy (DMD) and of its protein product, dystrophin, has led to the identification of biochemical homologues of this disease in the mouse, the dog and the cat.
openaire   +2 more sources

RELEVANCE OF GENETIC ANIMAL MODELS OF MUSCULAR DYSTROPHY TO HUMAN MUSCULAR DYSTROPHIES

Annals of the New York Academy of Sciences, 1979
Mendell, J R, Higgins, R, Sahenk, Z, Cosmos, E   +3 more
openaire   +2 more sources

Muscular dystrophy of mink: a new animal model.

Federation proceedings, 1976
Muscular dystrophies comprise an important group of inherited disorders of man. Although the disease has been studied extensively, little is known about the underlying primary pathomechanisms. Consequently, treatment of patients is difficult and prognosis is poor. An animal model of muscular dystrophy is a useful research tool for approaching the basic
G A, Hegreberg, M J, Hamilton, G A, Padgett   +2 more
openaire   +1 more source

Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer

Ca-A Cancer Journal for Clinicians, 2023
Miriam B. Garcia, Steven K Clinton, Kerry S Courneya   +2 more
exaly  

[Animal models for muscular dystrophy--muscular dystrophy in mice].

Nihon rinsho. Japanese journal of clinical medicine, 1978
S, Tsuji, H, Matsushita
openaire   +1 more source

Interventions for muscular dystrophy: molecular medicines entering the clinic

Lancet, The, 2009
Hanns Lochmüller, Volker Straub
exaly  

Pharmacological strategies for muscular dystrophy

Nature Reviews Drug Discovery, 2003
Tejvir S Khurana, Kay E Davies
exaly  

Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption

Journal of Cell Biology, 1997
Volker Straub, Jeffrey S Chamberlain, Kevin P Campbell   +2 more
exaly  

Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study

Lancet, The, 2016
Richard S Finkel, Claudia A Chiriboga, John W Day   +2 more
exaly